BIO is Back in Boston to Celebrate 25 Years of Innovation
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centres and related organizations across the United States and in more than 30 other nations.
The key benefits of attending the 2018 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries.
Abzena will be exhibiting at stand 1029 where we will be giving the following presentations throughout the conference:
- T1: Next Generation “SMART” Biomanufacturing Facility Design by Jim Mills, Abzena and Miriam Monge, Sartorius
- T2: Risk mitigation and managing unwanted immune responses to protein therapeutics including utilisation of MHC-associated peptide proteomics (MAPPs) by Dr. Gary Bembridge, Abzena
- T3: Strategic value through end-to-end solution to enable better biopharmaceutical for faster discovery, development, and manufacturing by Sven Lee, Abzena